CSOP Hang Seng Biotech ETF (03174.HK): Up 1.66% Intraday at HK$3.80
NewTimeSpace News: As of 13:23, August 25, 2026, CSOP Hang Seng Biotech ETF (03174.HK) gained 1.66% and traded at HK$3.80. The ETF recorded trading volume of 1.4011 million shares, turnover of HK$5.2878 million, an average price of HK$3.774, volume ratio of 1.00, turnover rate of 0.55% and amplitude of 2.19%. Its current net asset value per unit stands at HK$3.744, with AUM of HK$954 million, and each board lot comprises 100 shares.
CSOP Hang Seng Biotech ETF (03174.HK) tracks the Hang Seng Biotech Index. It focuses on leading biotech companies listed in Hong Kong, covering sectors including innovative pharmaceuticals, CXO, vaccines and gene therapy.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.96% in Morning Trade, AUM at HKD 954 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Falls 2.49% in Morning Trade, Turnover at HKD 2.323 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 4.65%, Turnover Reaches HKD 21.3876 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 6.06% in Morning Trade, Turnover at HKD 130.0611 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.87%, Turnover Reaches HKD 5.0272 Million